- Home
- MLYS vs FMNB Comparison
MLYS vs FMNB Comparison
Compare MLYS & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- FMNB
- Stock Information
- Founded
- MLYS 2019
- FMNB 1887
- Country
- MLYS United States
- FMNB United States
- Employees
- MLYS N/A
- FMNB 682
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- FMNB Major Banks
- Sector
- MLYS Health Care
- FMNB Finance
- Exchange
- MLYS Nasdaq
- FMNB Nasdaq
- Market Cap
- MLYS 890.6M
- FMNB 555.3M
- IPO Year
- MLYS 2023
- FMNB N/A
- Fundamental
- Price
- MLYS $36.88
- FMNB $14.53
- Analyst Decision
- MLYS Strong Buy
- FMNB Buy
- Analyst Count
- MLYS 6
- FMNB 2
- Target Price
- MLYS $42.60
- FMNB $15.50
- AVG Volume (30 Days)
- MLYS 2.6M
- FMNB 83.7K
- Earning Date
- MLYS 11-10-2025
- FMNB 10-22-2025
- Dividend Yield
- MLYS N/A
- FMNB 4.62%
- EPS Growth
- MLYS N/A
- FMNB N/A
- EPS
- MLYS N/A
- FMNB 1.34
- Revenue
- MLYS N/A
- FMNB $169,441,000.00
- Revenue This Year
- MLYS N/A
- FMNB $20.80
- Revenue Next Year
- MLYS N/A
- FMNB $8.33
- P/E Ratio
- MLYS N/A
- FMNB $10.98
- Revenue Growth
- MLYS N/A
- FMNB 0.20
- 52 Week Low
- MLYS $8.24
- FMNB $11.58
- 52 Week High
- MLYS $39.20
- FMNB $16.29
- Technical
- Relative Strength Index (RSI)
- MLYS 82.89
- FMNB 47.72
- Support Level
- MLYS $34.59
- FMNB $14.83
- Resistance Level
- MLYS $39.20
- FMNB $15.15
- Average True Range (ATR)
- MLYS 2.70
- FMNB 0.24
- MACD
- MLYS 0.98
- FMNB -0.08
- Stochastic Oscillator
- MLYS 90.21
- FMNB 8.49
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.